Technical expert Sudarshan Sukhani of s2analytics.com in an interview to CNBC-TV18 said it is very important to now focus on the midcaps because even if the market keeps moving up, it will be a slow rally
In a warning letter to the drug firm's Chairman V V Subba Reddy, the US Food and Drug Administration (USFDA) said its investigator "identified significant violations of current good manufacturing practice (CGMP) regulations for finished pharmaceuticals...".
The company had earlier in May announced that the US Food and Drug Administration (USFDA) had issued an import alert on its Waluj facility, which makes injectables and solid dosages.